xCures
United States, Oakland, California
About xCures
xCures is a US healthcare-AI company that turns the industry's fragmented, unstructured patient data into usable clinical intelligence. Founded in 2018 as a spinout from Cancer Commons, it pivoted from advanced-cancer decision support to building a "Clinical Clarity Engine" that connects to national health-data interoperability networks and uses a governed mix of in-house and commercial frontier AI models to locate, extract, normalize, and structure messy medical records. The platform has processed more than 300 million records from over 550,000 healthcare locations, serving lab-diagnostics companies, hospital networks, telehealth providers, and Medicare Advantage plans.
Latest Funding
Series BAnnounced 2026-06-24
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
2 signals · where the capital is going
Intentionally entering a capital-burn phase to build out the team for its 2027 business pipeline.
news.crunchbase.com
+1 more capital deployment signal · confidence ratings · source articles
Sign up freeHiring Signals
4 open roles · capital meeting headcount
R&D spend backed by 3 engineering hires, product build in motion
3 engineering roles, technical investment focus
+2 more hiring signals · full department matrix · role-by-role drill-down
Sign up freeTop hiring departments
In the news
Selling to xCures? You're in the right place.
Knowing they raised is the start. The edge is what's attached to xCures.
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Ask AI
What is the unique value proposition of xCures, and who are their main competitors?
Sign up free to ask AI about xCures
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
iGrow Venture Partners
Lead investor · Series B
Tech Stack
Contacts
Sarah M.
Head of Sales
Sample preview. Sign up free to see real contacts
Key Highlights
AI Insights$46M Series B led by Innovius Capital (with iGrow, Spring Mountain Capital and existing backers) at a $127M post-money valuation -- more than double its Dec-2023 Series A; total funding now exceeds $76M.
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to xCures
Selling to xCures? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to xCures.
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card. Five minutes, no approvals.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.